29th Annual Meeting of the American Society of Photobiology

Downtown Marriot

Chicago, Il.

July 7th-12th, 2001


Targeting UVB Induced AP-1 Activation for Chemoprevention of Skin Cancer

Bowden, G. Tim1, Chen, Weixing2, Gregus, Jacalyn1, Tang, Qingbo1 and Dong, Zigang3
The University of Arizona, Tucson, AZ 857241
Scripps Research Institute, La Jolla, CA 920372
The Hormel Institute, Austin, MN 559123

Abstract-
Non-melanoma skin cancer caused by sunlight is a significant public health problem in the US. The use of sunscreens is not totally effective in preventing these cancers. Therefore, there is interest in developing topical agents with different mechanisms of action to be used in combination with sunscreens. Tumor promoting effects of UVB irradiation are, in part, due to the activation of the transcription factor complex, activator protein-1 (AP-1). This was demonstrated using transgenic mice expressing a dominant negative mutant c-jun transgene in the epidermis. This transgene inhibits UVB induced AP-1 activation in keratinocytes and UVB induced skin tumors are inhibited in these transgenic mice. By understanding the UVB signal transduction pathway in both cultured mouse and human keratinocytes that leads to AP-1 activation we are developing agents that block this signaling pathway at different points. We have found in human keratinocytes that UVB induced AP-1 activation involves activation of both p38 and ERK kinases that mediate transcriptional activation of c-fos. In turn, c-Fos protein dimerizes with JunD to activate the AP-1. We have investigated the mechanism of action of the chemoprevention agent from green tea, (-)-epigallocatechin gallate (EGCG), and found that EGCG inhibits UVB induced AP-1 activation by blocking p38 activation which leads to c-fos transcription. We have also found that perillyl alcohol that has been reported to inhibit ras farnesylation inhibits UVB induced AP-1 activation in mouse skin and human keratinocytes. We showed topical perillyl alcohol inhibits UVB induced mouse skin carcinogenesis. Finally, we have recently shown that an AP-1 selective retinoid, SR11302, inhibits UVB induced AP-1 activation in mouse skin and human keratinocytes. This retinoid is being tested for its chemoprevention activity. Therefore, we have demonstrated that agents that block UVB signal transduction at different steps in signaling have chemoprevention activity in inhibiting UVB induced mouse skin carcinogenesis.

Keywords: chemoprevention, uvb-induced ap-1 activation, (-)-epigallocatechin gallate